ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Evelyne Grisard et al.|Cancer Research|2012Cited by 131
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker valuePascale A. Cohen, Julie A. Vendrell, Caterina F. Donini et al.|Oncotarget|2015Cited by 66
A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancersNhan Trung Nguyen, Pascale A. Cohen, Isabelle Treilleux et al.|Molecular Oncology|2014Cited by 34